NCT05068388Phase 2Completed

Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density

Study sponsor: Atossa Therapeutics, Inc. · ATOS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-06-14Actual
Enrollment · participants240Actual
Source updated2026-05-20Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 28 Aug 2024. After: 14 Jun 2024.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview